Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

XBiotech Inc. Director's Dealing 2019

Jun 6, 2019

34229_dirs_2019-06-06_d4921089-e22e-4b3e-9daa-07ecd760f85c.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: XBiotech Inc. (XBIT)
CIK: 0001626878
Period of Report: 2019-06-04

Reporting Person: RENNES FONDATION (10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2019-06-04 Common Stock P 1200000 $8.25 Acquired 5110282 Direct

Footnotes

F1: Represents a purchase from the underwriter in the Issuer's public offering.